Musculoskeletal Pain in Patients With Chronic Myeloid Leukemia After Discontinuation of Imatinib: A Tyrosine Kinase Inhibitor Withdrawal Syndrome? Reply

被引：11

作者：

Rousselot, Philippe ^{[1
]}

Charbonnier, Aude ^{[2
]}

Cony-Makhoul, Pascale ^{[3
]}

Agape, Philippe ^{[4
]}

Nicolini, Franck E. ^{[5
]}

Varet, Bruno ^{[6
,7
]}

Gardembas, Martine ^{[8
]}

Etienne, Gabriel ^{[9
]}

Rea, Delphine ^{[10
]}

Roy, Lydia ^{[11
]}

Escoffre-Barbe, Martine ^{[12
]}

Guerci-Bresler, Agnes ^{[13
]}

Tulliez, Michel ^{[14
]}

Prost, Stephane ^{[15
]}

Spentchian, Marc ^{[16
]}

Cayuela, Jean Michel ^{[10
]}

Reiffers, Josy ^{[17
]}

Chomel, Jean Claude ^{[18
,19
]}

Turhan, Ali ^{[18
,19
]}

Guilhot, Joelle ^{[20
]}

Guilhot, Francois ^{[20
]}

Mahon, Francois-Xavier ^{[21
,22
]}

机构：

[1] Univ Versailles St Quentin en Yvelines, Hop Mignot, Versailles, France

[2] Inst Paoli Calmette, Marseille, France

[3] Hop Annecy, Pringy, France

[4] Ctr Hop Univ CHU Reunion, Hop Felix Guyon, St Pierre, Reunion, France

[5] Ctr Hosp Lyon Sud, Pierre Benite, France

[6] Hop Necker Enfants Malad, AP HP, Paris, France

[7] Univ Paris 05, Paris, France

[8] CHU Angers, Angers, France

[9] Inst Bergonie, Bordeaux, France

[10] Hop St Louis, AP HP, Paris, France

[11] CHU Poitiers, INSERM, Clin Invest Ctr CIC 802, Poitiers, France

[12] Ctr Hosp Pontchaillou, Rennes, France

[13] CHU Brabois Vandoeuvre, Nancy, France

[14] Hop Henri Mondor, AP HP, Paris, France

[15] Inst Emerging Dis & Innovat Therapies, Fontenay Aux Roses, France

[16] Hop Mignot, Le Chesnay, France

[17] Inst Bergonie, Bordeaux, France

[18] Univ Poitiers, INSERM U935, Le Kremlin Bicetre, France

[19] Univ Paris 11, Le Kremlin Bicetre, France

[20] CHU Poitiers, INSERM CIC 802, Poitiers, France

[21] Hop Haut Leveque, INSERM U1035, Bordeaux, France

[22] Univ Bordeaux Segalen, Bordeaux, France

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 25期

关键词：

COMPLETE MOLECULAR REMISSION; CHRONIC MYELOGENOUS LEUKEMIA; MESYLATE; THERAPY; DISEASE;

D O I：

10.1200/JCO.2014.56.3858

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2823 / +

页数：3

共 50 条

[21] Patient-Initiated Discontinuation of Tyrosine Kinase Inhibitor for Chronic Myeloid Leukemia
Langabeer, Stephen E.
Faryal, Rehman
O'Dwyer, Michael
Loingsigh, Sorcha Ni
CASE REPORTS IN HEMATOLOGY, 2020, 2020
[22] Does the Frequency of Molecular Monitoring After Tyrosine Kinase Inhibitor Discontinuation Affect Outcomes of Patients With Chronic Myeloid Leukemia?
Kong, Jee Hyun
Winton, Elliott F.
Heffner, Leonard T.
Chen, Zhengjia
Langston, Amelia A.
Hill, Brittany
Arellano, Martha
El-Rassi, Fuad
Kim, Audrey
Jillella, Anand
Kota, Vamsi K.
Bodo, Imre
Khoury, Hanna Jean
CANCER, 2017, 123 (13) : 2482 - 2488
[23] What are the considerations for tyrosine kinase inhibitor discontinuation in chronic-phase chronic myeloid leukemia?
Harrington, Patrick
Radia, Deepti
de Lavallade, Hugues
EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (03) : 213 - 222
[24] Subsequent attempt tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia; a single institute experience
Ureshino, Hiroshi
Kamachi, Kazuharu
Nishioka, Atsujiro
Okamoto, Sho
Katsuya, Hiroo
Yoshimura, Mariko
Kubota, Yasushi
Ando, Toshihiko
Kimura, Shinya
HEMATOLOGICAL ONCOLOGY, 2021, 39 (04) : 549 - 557
[25] Higher neutrophil counts are associated with successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia
Ureshino, Hiroshi
Kamachi, Kazuharu
Sano, Haruhiko
Okamoto, Sho
Itamura, Hidekazu
Yoshimura, Mariko
Katsuya, Hiroo
Ando, Toshihiko
Kimura, Shinya
HEMATOLOGY, 2022, 27 (01) : 1171 - 1175
[26] Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia
Mario Tiribelli
Ahmet Emre Eskazan
Oncology and Therapy, 2019, 7 : 95 - 100
[27] Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia
Tiribelli, Mario
Eskazan, Ahmet Emre
ONCOLOGY AND THERAPY, 2019, 7 (02) : 95 - 100
[28] Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia
Takahashi, Naoto
Kyo, Taiichi
Maeda, Yasuhiro
Sugihara, Takashi
Usuki, Kensuke
Kawaguchi, Tatsuya
Usui, Noriko
Okamoto, Shinichiro
Ohe, Yokiko
Ohtake, Shigeki
Kitamura, Kunio
Yamamoto, Masahide
Teshima, Hirofumi
Motoji, Toshiko
Tamaki, Toshiharu
Sawada, Kenichi
Ohyashiki, Kazuma
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (06): : 903 - 906
[29] An unexpected new adverse event after imatinib discontinuation in patients with chronic myelogenous leukemia: a withdrawal syndrome?
Chenaf, C.
Oris, C.
Saugues, S.
Bourgne, C.
Tournilhac, O.
Eschalier, A.
Berger, M.
Zenut, M.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2015, 29 : 25 - 25
[30] Role of Folate Receptor 3 in Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia
Shen, Na
Zhu, Xiaojian
Zhou, Shu
You, Yong
Zhong, Zhaodong
Zhu, Xiaoying
Li, Qing
Zou, Ping
Zhang, Yicheng
BLOOD, 2018, 132

← 1 2 3 4 5 →